Some studies show these drugs might help with depression
Many patients achieve optimal results by combining GLP-1 therapy with complementary services such as hormone replacement therapy, peptide therapy, or vitamin injections
In people with both type 2 diabetes and obesity, an indirect comparison drawing on the separate SURMOUNT-2 (NCT04657003) and STEP 2 (NCT03552757) trials, rather than a single head-to-head study, reported weight reduction of up to 15.7% with tirzepatide and 10.6% with semaglutide 2.4 mg
Weight-Loss Care Trends: Certifications, Mental Health, and the Push for Oral GLP-1s: Certifications: Despite 81% reporting prescribing any medications for weight loss or a weight loss benefit in the past year, 67% of those surveyed report not having any Obesity Treatment Certification, such as the American Board of Obesity Medicine or European Association Study of Obesity Medicine
What to watch for: GI side effects often increase with this first dose bump